Neuracle
Latest round
- Series C
Last raised
- Dec 2022
Total raised
- $24M
Investors
- 6
About Neuracle
Established in 2011 and based in Changzhou, China, Neuracle is a solution provider with a core team from Top 5 Global Brain-Computer Intelligence Research Laboratories and medical market experts in the field of clinical neurology. In 2012, it completed the construction of Jiangsu Changzhou research, development and production base. The company won the special support of the National Twelfth Five-Year Plan and obtained a medical device production license in 2013. In 2017, it obtained the registration certificate of digital electroencephalography machine medical equipment and officially entered the medical field. Neuracle is a high-tech enterprise with independent innovation of "brain-computer interface" technology as the core, specializing in the research and development, production, sales and technical services of related equipment of brain-computer interface system. The company relies on the international leading brain-computer interface technology which is independently developed by Tsinghua University, committed to providing professional and complete solutions for neuroscience innovation research and clinical neurological disease diagnosis, treatment and rehabilitation research. For example: The digital EEG machine is a product independently developed by Neuracle. It is manufactured with scientific research level technology and has excellent anti-interference ability. It can collect high-quality signals in complex ICU environments. It has waveform measurement tool which can measure waveform amplitude and frequency. The digital EEG machine can be selected 8/16/32/40 to meet the needs of different departments. A variety of montage editors for clinical use. The products of neuracle were widely used in scientific research fields such as neuroscience, psychology, human factors engineering, Kinematics, management, etc. Besides, they are also used in clinical medical fields such as clinical neurological disease diagnosis, treatment and rehabilitation engineering. The company’s revenue is generated by providing clinical neurological disease diagnosis, treatment and rehabilitation solutions.
Who invested in Neuracle
6 investors across 3 rounds
See all investors in Neuracle
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neuracle
Who invested in Neuracle?
Neuracle has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neuracle raised?
Neuracle has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Neuracle last raise money?
Neuracle's most recent round on record is a Series C, in Dec 2022.
What does Neuracle do?
Established in 2011 and based in Changzhou, China, Neuracle is a solution provider with a core team from Top 5 Global Brain-Computer Intelligence Research Laboratories and medical market experts in the field of clinical neurology.
Where is Neuracle headquartered?
Neuracle is headquartered in Changzhou, China.
Which VCs invest in companies like Neuracle?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at Neuracle's stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series C
Raising like Neuracle? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.